Skip to main navigation
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Scholar Rock, Inc. Logo

Scholar Rock, Inc.

  • Careers
  • Newsroom
  • Contact Us
  • Patients & Families
    • Patients & Families
    • Areas of Focus
      • Spinal Muscular Atrophy
    • Patient Stories
    • Clinical Trials
    • Resources
    • Expanded Access

    Learn about our commitment to creating possibilities for those living with serious disease.

    Patients & Families

  • Our Company
    • Our Company
    • Mission & Vision
    • Newsroom
    • Careers
    • Management Team
    • Board of Directors

    Meet Scholar Rock, a biopharmaceutical company committed to improving lives.

    Our Company

  • Our Science
    • Our Science
    • Platform
    • Publications & Posters

    Discover how our breakthrough approach treats complex disease at its biological root.

    Our Science

  • Our Pipeline
    • Our Pipeline
    • Neuromuscular and Obesity
      • Spinal Muscular Atrophy
    • Cardiometabolic Disorders
    • Immuno-Oncology
      • Cancer (solid tumors)
    • Fibrotic Diseases
      • Fibrosis
    • Hematology
      • Anemia
  • Investors & Media
    • Investors & Media
    • Press Releases
      • Archived Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact IR or Media
Link to homepage Investors & Media Management Team Junlin Ho, JD

Investors and Media

Junlin Ho, J.D.

Main content section

Ho

Junlin Ho, J.D.

General Counsel & Corporate Secretary
Junlin Ho joined Scholar Rock in 2018 and has served as General Counsel & Corporate Secretary since February 2021, overseeing all legal affairs, including corporate governance, compliance, and intellectual property. She has over 15 years of experience leading and advising life sciences companies on various legal aspects associated with corporate governance, business development, financing, securities law, commercial product planning and launches, and international operations. Prior to Scholar Rock, she served as Associate General Counsel at Foundation Medicine where she helped lead the team in support of that company’s initial public offering and was a member of the team that negotiated a major strategic partnership. Additionally, Junlin served as Associate General Counsel, Corporate at Ziopharm Oncology and was a corporate attorney in the life sciences practice at the law firm Ropes & Gray LLP. She received her J.D. from the University of Chicago Law School and a B.S. from the Massachusetts Institute of Technology.

    Primary Sidebar

    Investor Menu

    • Investors & Media
    • Press Releases
      • Archived Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact IR or Media

    In this section

    Footer

    Scholar Rock, Inc.
    301 Binney Street, 3rd Floor
    Cambridge, MA 02142

    Phone: 857.259.3860
    info@scholarrock.com

    © 2026 All Rights Reserved
    • Community Guidelines
    • Expanded Access Policy
    • Privacy Policy
    • Terms of Use

    We are Scholar Rock.

    A biopharmaceutical company dedicated to discovering, developing, and delivering therapies that create new possibilities for patients.

    Learn More About Our Pipeline

    • Community Guidelines
    • Expanded Access Policy
    • Privacy Policy
    • Terms of Use
    Scholar Rock, Inc. Logo
    • Patients & Families
      • Areas of Focus
        • Spinal Muscular Atrophy
      • Patient Stories
      • Clinical Trials
      • Resources
      • Expanded Access
    • Our Company
      • Our Company
      • Mission & Vision
      • Newsroom
      • Careers
      • Management Team
      • Board of Directors
    • Our Science
      • Our Science
      • Platform
      • Publications & Posters
    • Our Pipeline
      • Neuromuscular and Obesity
        • Spinal Muscular Atrophy
      • Immuno-Oncology
        • Cancer (solid tumors)
        • Fibrotic Diseases
      • Hematology
        • Anemia
    • Investors & Media
      • Press Releases
        • Archived Press Releases
      • Events & Presentations
      • Corporate Governance
        • Management Team
        • Board of Directors
        • Committee Composition
      • Financials & Filings
        • SEC Filings
      • Stock Information
        • Historical Stock Lookup
        • Investment Calculator
        • Analyst Coverage
      • Investor FAQs
      • Contact IR or Media
    • Careers
    • Newsroom
    • Contact Us